CT-P39 + EU-approved Xolair + CT-P39 + EU-approved Xolair + US-licensed Xolair
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Healthy
Conditions
Healthy
Trial Timeline
May 28, 2020 → Apr 30, 2021
NCT ID
NCT04018313About CT-P39 + EU-approved Xolair + CT-P39 + EU-approved Xolair + US-licensed Xolair
CT-P39 + EU-approved Xolair + CT-P39 + EU-approved Xolair + US-licensed Xolair is a phase 1 stage product being developed by Celltrion for Healthy. The current trial status is completed. This product is registered under clinical trial identifier NCT04018313. Target conditions include Healthy.
What happened to similar drugs?
20 of 20 similar drugs in Healthy were approved
Approved (20) Terminated (1) Active (0)
✅Listerine Experimental Mouthwash + Colgate Cavity Protection Toothpaste + Listerine Total Care ZeroJohnson & JohnsonApproved
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04018313 | Phase 1 | Completed |
Competing Products
20 competing products in Healthy
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Use of Wearable Digital Sensors After mRNA Vaccination in Adults | Moderna | Preclinical | 0 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| mRNA-6231 | Moderna | Phase 1 | 0 |
| Letrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Isotretinoin | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Fexofenadine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sertraline | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Nizatidine + Axid | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Anastrozole | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-1273.712 | Moderna | Approved | 0 |
| Risperidone | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Metformin + Glucophage | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Lamotrigine | Dr. Reddy's Laboratories | Phase 1 | 26 |
| mRNA-0184 | Moderna | Phase 1 | 0 |
| Divalproex Sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Sirolimus | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Glimepiride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Ziprasidone Hydrochloride | Dr. Reddy's Laboratories | Phase 1 | 26 |
| Naproxen sodium | Dr. Reddy's Laboratories | Phase 1 | 26 |